Literature DB >> 5460839

Renal effects of calcitonin.

M Cochran, M Peacock, G Sachs, B E Nordin.   

Abstract

Porcine calcitonin in a slow-release gelatin vehicle was given by intramuscular injection to 10 patients-four with primary hyperparathyroidism, four with Paget's disease, and two with carcinoma of the breast and hypercalcaemia. All cases showed a fall in serum calcium with an immediate rise in urine calcium. All except three patients with primary hyperparathyroidism showed a fall in serum phosphorus, but an immediate rise in urine phosphorus occurred in all cases. Urine hydroxyproline output fell in three patients with severe Paget's disease. Urine sodium rose in all cases, but the effects on potassium, magnesium, water, and pH were not appreciably different from results obtained in four control subjects who were given the gelatin vehicle alone.The data suggest that calcitonin caused a decrease in the tubular resorption of calcium and phosphorus. The hypocalcaemic effect appeared to be due to a decrease in bone resorption in the patients with Paget's disease but in the remaining cases could be accounted for in part or entirely by the rise in urine calcium.

Entities:  

Mesh:

Substances:

Year:  1970        PMID: 5460839      PMCID: PMC1699071          DOI: 10.1136/bmj.1.5689.135

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  11 in total

1.  The effect of intravenous parathyroid extract on urinary pH, bicarbonate and electrolyte excretion.

Authors:  B E NORDIN
Journal:  Clin Sci       Date:  1960-05       Impact factor: 6.124

2.  Effects of calcitonin on patients with Paget's disease, thyrotoxicosis, or hypercalcaemia.

Authors:  O L Bijvoet; J van der Sluys Veer; A P Jansen
Journal:  Lancet       Date:  1968-04-27       Impact factor: 79.321

3.  Relation between serum and urinary calcium with particular reference to parathyroid activity.

Authors:  M Peacock; W G Robertson; B E Nordin
Journal:  Lancet       Date:  1969-02-22       Impact factor: 79.321

4.  [Study of the hypocalcemic mechanism of action of thyrocalcitonin].

Authors:  G Milhaud; A M Perault; M S Moukhtar
Journal:  C R Acad Hebd Seances Acad Sci D       Date:  1965-07-19

5.  Effect of calcium administration and deprivation on serum and urine calcium in stone-forming and control subjects.

Authors:  M Peacock; F Knowles; B E Nordin
Journal:  Br Med J       Date:  1968-06-22

6.  Hog thyrocalcitonin in the dog: urinary calcium, phosphorus, magnesium and sodium responses.

Authors:  J D Clark; A D Kenny
Journal:  Endocrinology       Date:  1969-05       Impact factor: 4.736

7.  Bone turnover model based on a continuously expanding exchangeable calcium pool.

Authors:  L Burkinshaw; D H Marshall; C B Oxby; F W Spiers; B E Nordin; M M Young
Journal:  Nature       Date:  1969-04-12       Impact factor: 49.962

8.  Thyrocalcitonin: inhibitor of bone resorption in tissue culture.

Authors:  J Friedman; L G Raisz
Journal:  Science       Date:  1965-12-10       Impact factor: 47.728

9.  Thyrocalcitonin inhibition of bone resorption induced by parathyroid hormone in tissue culture.

Authors:  M A Aliapoulios; P Goldhaber; P L Munson
Journal:  Science       Date:  1966-01-21       Impact factor: 47.728

10.  [Effects of thyrocalcitonin on the renal excretion of phosphates, calcium and hydrogen ions in man].

Authors:  R Ardaillou; P Vuagnat; G Milhaud; G Richet
Journal:  Nephron       Date:  1967       Impact factor: 2.847

View more
  12 in total

Review 1.  Calcitonin and calcitonin receptors: bone and beyond.

Authors:  M Pondel
Journal:  Int J Exp Pathol       Date:  2000-12       Impact factor: 1.925

2.  The effect of calciferol, parathormone and calcitonin on the biochemical composition of kidney.

Authors:  A Komárková; I Bilyk; Z Záhor; V Czabanova
Journal:  Experientia       Date:  1972-04-15

3.  The effects of salmon calcitonin-induced hypocalcemia on bone metabolism in ovariectomized rats.

Authors:  Rachel A Davey; Howard A Morris
Journal:  J Bone Miner Metab       Date:  2005       Impact factor: 2.626

4.  Plasma Citrate Homeostasis: How It Is Regulated; And Its Physiological and Clinical Implications. An Important, But Neglected, Relationship in Medicine.

Authors:  Leslie C Costello; Renty B Franklin
Journal:  HSOA J Hum Endocrinol       Date:  2016-12-31

5.  Metabolic balance studies in patients with Paget's disease receiving salmon calcitonin over long periods.

Authors:  D G Oreopoulos; H Husdan; J Harrison; H E Meema; K G McNeill; T M Murray; R Ogilvie; A Rapoport
Journal:  Can Med Assoc J       Date:  1977-04-23       Impact factor: 8.262

6.  Early effects of synthetic bovine parathyroid hormone and synthetic salmon calcitonin on urinary excretion of cyclic AMP, phosphate and calcium in man.

Authors:  A Caniggia; C Gennari; A Vattimo; P Nardi; R Nuti; M Galli
Journal:  Calcif Tissue Res       Date:  1976-04-20

7.  Quantitation of the renal effect of calcitonin in the hypercalcaemia of malignancy.

Authors:  D J Hosking; S R Heller
Journal:  Eur J Clin Pharmacol       Date:  1986       Impact factor: 2.953

8.  Renal effects of calcitonin and parathyroid extract in man. Studies in hypoparathyroidism.

Authors:  H G Haas; M A Dambacher; J Guncaga; T Lauffenbruger
Journal:  J Clin Invest       Date:  1971-12       Impact factor: 14.808

Review 9.  Drugs used in the treatment of metabolic bone disease. Clinical pharmacology and therapeutic use.

Authors:  S Patel; A R Lyons; D J Hosking
Journal:  Drugs       Date:  1993-10       Impact factor: 9.546

10.  Value of plasma chloride concentration and acid-base status in the differential diagnosis of hyperparathyroidism from other causes of hypercalcaemia.

Authors:  M R Wills
Journal:  J Clin Pathol       Date:  1971-04       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.